# Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy.

> **NCT07751861** · NA · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 176 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DEVICE:** low concentrated citrate solution (18 mmol/L)
- **DEVICE:** high concentrated citrate solution (136 mmol/L)

## Key facts

- **NCT ID:** NCT07751861
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-04-01
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751861, "Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*